The ANAsclplus Dot is a qualitative dot immunoassay for the determination of IgG antibodies against nuclear and cytoplasmic antigens (Sm, Sm/RNP, SS-A, SS-B, Jo-1 (histidyl-t-RNA synthetase), Scl-70 (topoisomerase I), PmScl, Ku, CENP-A/B (Centromer proteins A and B), PCNA (proliferating cell nuclear antigen)) in human serum. The ANAsclplus Dot is intended as an aid in the diagnosis of systemic autoimmune diseases in conjunction with other clinical and laboratory findings. The immunoassay is designed for manual professional in vitro diagnostic use.
4074 – ANAsclplus Dot
Autoimmunity, Diagnostics, LINE / Dot
4074 – ANAsclplus Dot
Dot Immunoassay for the determination of IgG antibodies against nuclear and cytoplasmic antigens in human serum
Available Downloads:
| Indication | Systemic autoimmune diseases |
|---|---|
| Format | Test strips coated with Sm, Sm/RNP, SS-A, SS-B, Jo-1, Scl-70, PmScl, Ku, CENP-A/B and PCNA |
| Total incubation time | 80 min |
| Sample volume | 10 µL serum |
| No. of determinations | 24 x 10 |
Related products
-
3750 – Anti-GP2 IgA
Enzyme immunoassay for the quantitative determination of IgA antibodies against glycoprotein 2 (GP2) in human serum
-
8064 – CytoBead® CeliAK
Indirect immunofluorescence assay for the qualitative and semi-quantitative determination of IgA or IgG antibodies in human serum against endomysium, tissue transglutaminase (tTG) and deamidated gliadin (DG) as well as for control of IgA antibodies
-
8065 – CytoBead® ANA
Indirect immunofluorescence assay for the determination of IgG antibodies in human serum against nuclear and cytoplasmic antigens